Cargando…

Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing

BACKGROUND. Variation in Clostridium difficile infection (CDI) rates between healthcare institutions suggests overall incidence could be reduced if the lowest rates could be achieved more widely. METHODS. We used whole-genome sequencing (WGS) of consecutive C. difficile isolates from 6 English hospi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eyre, David W., Fawley, Warren N., Rajgopal, Anu, Settle, Christopher, Mortimer, Kalani, Goldenberg, Simon D., Dawson, Susan, Crook, Derrick W., Peto, Tim E. A., Walker, A. Sarah, Wilcox, Mark H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850028/ https://www.ncbi.nlm.nih.gov/pubmed/28575285 http://dx.doi.org/10.1093/cid/cix338

Ejemplares similares

Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
por: Martin, Jessica S H, et al.
Publicado: (2018)

Hash-Based Core Genome Multilocus Sequence Typing for Clostridium difficile
por: Eyre, David W., et al.
Publicado: (2019)

Evolutionary History of the Clostridium difficile Pathogenicity Locus
por: Dingle, Kate E., et al.
Publicado: (2013)

Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
por: Eyre, David W, et al.
Publicado: (2018)

Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile
por: Eyre, David W., et al.
Publicado: (2014)

Short-Term Genome Stability of Serial Clostridium difficile Ribotype 027 Isolates in an Experimental Gut Model and Recurrent Human Disease
por: Eyre, David W., et al.
Publicado: (2013)

An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
por: Davies, Kerrie, et al.
Publicado: (2020)

Comparison of Multilocus Variable-Number Tandem-Repeat Analysis and Whole-Genome Sequencing for Investigation of Clostridium difficile Transmission
por: Eyre, D. W., et al.
Publicado: (2013)

Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
por: Dingle, Kate E., et al.
Publicado: (2011)

Asymptomatic Clostridium difficile Colonisation and Onward Transmission
por: Eyre, David W., et al.
Publicado: (2013)

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
por: Eyre, David W., et al.
Publicado: (2012)

A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078
por: Dingle, Kate E., et al.
Publicado: (2019)

Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains
por: Stoesser, Nicole, et al.
Publicado: (2017)

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
por: Eyre, David W., et al.
Publicado: (2019)

Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
por: Walker, A. Sarah, et al.
Publicado: (2013)

Detection of Mixed Infection from Bacterial Whole Genome Sequence Data Allows Assessment of Its Role in Clostridium difficile Transmission
por: Eyre, David W., et al.
Publicado: (2013)

Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing
por: Walker, A. Sarah, et al.
Publicado: (2012)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
por: Didelot, Xavier, et al.
Publicado: (2012)

Effects of control interventions on Clostridium difficile infection in England: an observational study
por: Dingle, Kate E, et al.
Publicado: (2017)

Community Environmental Contamination of Toxigenic Clostridium difficile
por: Alam, M Jahangir, et al.
Publicado: (2017)

Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains
por: Nale, Janet Y., et al.
Publicado: (2012)

Incidence and Costs of Clostridium difficile Infections in Canada
por: Levy, Adrian R., et al.
Publicado: (2015)

Surveillance of Infection Severity: A Registry Study of Laboratory Diagnosed Clostridium difficile
por: Schlackow, Iryna, et al.
Publicado: (2012)

A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance
por: Eyre, David W, et al.
Publicado: (2012)

Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile
por: Wiens, Jenna, et al.
Publicado: (2014)

Changing Results to Change Results: Nudging Antimicrobial Prescribing for Clostridium difficile
por: Herman, Dakoda J, et al.
Publicado: (2020)

The Complexity and Diversity of the Pathogenicity Locus in Clostridium difficile Clade 5
por: Elliott, Briony, et al.
Publicado: (2014)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
por: Dantes, Raymund, et al.
Publicado: (2015)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

Using Machine Learning and the Electronic Health Record to Predict Complicated Clostridium difficile Infection
por: Li, Benjamin Y, et al.
Publicado: (2019)

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
por: Cornely, Oliver A., et al.
Publicado: (2012)

Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia
por: Salazar, Clara Lina, et al.
Publicado: (2017)

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
por: Vihta, Karina Doris, et al.
Publicado: (2021)

Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom
por: Vihta, Karina-Doris, et al.
Publicado: (2022)

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
por: Crook, Derrick W., et al.
Publicado: (2012)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission
por: Lee, Lennard Y W, et al.
Publicado: (2021)

Human and Porcine Transmission of Clostridioides difficile Ribotype 078, Europe
por: Moloney, Geraldine, et al.
Publicado: (2021)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
por: Soriano, Melinda M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e2h899d4ki1jkodmrqe3qctjf2